McGraner Matt

Matt McGraner buys 2,000 NXRT shares at $24.37; stock down -38.3% from 52-week high, company unprofitable.

McGraner purchased 2,000 shares at $24.37 on 2026-03-20, adding to holdings that now total 331,334 shares. This represents the fourth consecutive buy at NXRT within a 15-day window (2026-03-05 through 2026-03-20), suggesting sustained accumulation amid significant price deterioration. The stock has fallen -38.3% from its 52-week high and is down -15.6% over the past 30 days, while the company reported a negative net income of $-7,790,000.00 for the latest quarter and annual revenue growth of -3.2%. McGraner's cross-ticker track record shows strong execution (11 prior buys, 100% 90-day win rate, avg 90d return +24.5%), but this specific ticker context—repeated purchases into a declining, unprofitable business—departs from his historical pattern and warrants scrutiny of the underlying catalyst.

McGraner Matt bought 1,000 shares of NXRT at $26.14 on 2026-03-11; stock now -36.8% from 52-week high.

McGraner Matt purchased 1,000 shares at $26.14, adding to recent buys on 2026-03-09 and 2026-03-06, increasing his holdings to 316,821 shares. However, the stock has declined 36.8% from its 52-week high of $40.68 and trades 17.6% lower over the past 30 days, suggesting the recent purchase window has coincided with material price weakness. The company reported a net loss of $7,790,000 over its most recent fiscal year and revenue contracted 3.2% year-over-year, indicating operational headwinds that may be weighing on valuation. While McGraner's cross-ticker track record shows a 100% 90-day win rate on prior buys, his three trades at NXRT in the past week remain unmeasurable, and the timing of accumulation into a declining stock amid deteriorating fundamentals merits investor attention.

McGraner Matt bought 1,000 shares of NXRT at $26.39 on 2026-03-09; stock now at -35.3% from 52-week high and 90-day decline.

McGraner Matt purchased 1,000 shares at $26.39, adding to holdings now totaling 315.8K shares—a modest 0.3% increase. The stock is trading significantly depressed relative to its 52-week range, down 35.3% from the high and declining 12.6% over the past 30 days and 11.9% over 90 days. This purchase occurs within a pattern of three consecutive buys at NXRT over a 6-day window (2026-03-05, 2026-03-06, 2026-03-11), suggesting continued accumulation during a sustained price decline. The underlying company remains unprofitable with net income of $-7.8M in the latest quarter and annual revenue contraction of 3.2%, which adds material context to the timing and conviction of the insider's recent buying activity.

McGraner Matt bought 2,000 shares of NXRT totaling $55,150.00 at avg $27.58; company unprofitable and stock -35.0% from 52-week high

McGraner Matt executed 2 separate open-market purchases totaling 2,000 shares for $55,150.00 on 2026-03-05 and 2026-03-06 at blended average price $27.58. This represents a modest 0.6% increase to his holdings of 314,821 shares post-transaction. The purchase occurs in a deteriorating context: NXRT trades at $26.87, down 35.0% from its 52-week high of $41.31 and down 11.6% over the past 30 days. The company is unprofitable with net income of $-7,790,000.00 over its most recent full fiscal year and posted negative $7,790,000.00 net income in the latest quarter. While McGraner's cross-ticker track record shows 8 prior buys with an average 90-day return of +24.5% at a 100.00% win rate, this transaction occurred below the current market price and within the context of revenue decline (-3.2% annual growth). His prior activity at NXRT is limited to a buy on 2026-03-09, which is not yet measurable at the 90-day mark.

McGraner Matt bought 15,000 shares of NXDT for $80,600 on 2024-07-08; cluster buy pattern with 2 other insiders in past 14 days.

McGraner Matt purchased 15,000 shares across 2 separate transactions totaling $80,600.00, expanding his holdings by 22.9% to 80,386 shares. This buying activity coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. However, the broader context reveals material headwinds. NXDT reported a net income of $-21,548,000.00 in the latest quarter and was unprofitable over its most recent full fiscal year. Additionally, the stock has declined 19.0% over the past 90 days and trades 59.0% below its 52-week high of $12.80, despite a modest 5.8% gain over the past 30 days. The insider's cross-ticker track record shows 100% win rate on prior buys with 90-day average returns of +30.4%, though none of his 3 prior trades at NXDT have yet reached the 90-day measurement threshold to validate timing at this specific ticker.

McGraner bought 5,000 NXDT shares at $4.74 on 2024-06-21, +8.5% increase in holdings as stock down 61.6% from 52-week high

McGraner Matt purchased 5,000 shares at $4.74, raising his holdings from 58,965 to 63,965 shares—a meaningful +8.5% increase. This buy follows two additional purchases at the same ticker within 8 days (2024-06-18 and 2024-06-13), suggesting sustained accumulation despite deteriorating fundamentals: NexPoint reported a $-21.5M net loss over its most recent full fiscal year. The stock is trading at $4.91, down 61.6% from its 52-week high of $12.80 and down 7.7% over 30 days. While McGraner's cross-ticker track record shows strong 90-day outcomes (100% win rate, +30.4% average), his prior trades at NXDT are too recent to measure, and his historical timing data provides no signal for this specific ticker. The cluster pattern—2 other insiders also buying within 14 days—indicates broader confidence, but the company's unprofitability and steep recent decline warrant investor scrutiny of whether these purchases reflect opportunistic accumulation or conviction in a turnaround.

NXDT insider McGraner buys 5,000 shares ($24.2K) at $4.83; stock down -63.0% from 52-week high amid cluster buying pattern

McGraner purchased 5,000 shares at $4.83 on 2024-06-18, increasing holdings to 58,965 shares—a 9.3% position increase. The transaction occurs as the stock trades 63.0% below its 52-week high of $12.80 and has declined 16.0% over the past 30 days. At the same time, 2 other insiders have bought within the past 14 days, forming a cluster buying pattern. However, NXDT's fundamentals remain stressed: the company reported net income of -$21.5M on revenue of $12.8M and maintains negative full-year profitability. While McGraner's cross-ticker track record shows 3 prior buys averaging +30.4% returns over 90 days, his prior NXDT purchase (2024-06-13) remains unmeasurable in outcome, and no same-ticker timing data is yet available to assess whether this accumulation pattern aligns with value emergence or continued deterioration.

McGraner Matt bought 5,000 NXDT shares at $4.93; stock now down 62.7% from 52-week high amid unprofitability.

McGraner Matt purchased 5,000 shares at $4.93, increasing his holdings by 10.2% to 54.0K shares. The purchase occurs while NXDT is severely depressed: the stock trades at $4.78, down 62.7% from its 52-week high of $12.80 and down 19.3% over the prior 30 days. Fundamentally, the company reported a net loss of $-21.5M against quarterly revenue of $12.8M and carries negative full-year net income, indicating sustained unprofitability. McGraner's cross-ticker track record shows a 100% win rate on his 2 prior open-market buys with a 90-day average return of 30.4%, though that prior success does not guarantee similar outcomes in a fundamentally challenged situation. The convergence of depressed price action with substantial operating losses warrants investor attention to the company's operational recovery path.